Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis.
Evidence for Borna disease virus infection in neuropsychiatric patients in three western China provinces.
Chronic inflammatory demyelinating polyneuropathy with papillodema and response to immunoglobulins.
Erratum to: Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex(®)) for Spasticity in Multiple Sclerosis.
Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
Preliminary study on patients located at the Kashani/Isfahan Hospital with multiple sclerosis between the years 2011 and 2013.
Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients.
Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis.
Fatigue in Multiple Sclerosis Compared to Stroke.
Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis.
Association of Autophagy in the Cell Death Mediated by Dihydrotestosterone in Autoreactive T Cells Independent of Antigenic Stimulation.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
[Anti-neurofascin antibody in combined central and peripheral demyelination].
Effect Of Fingolimod On Disease Progressions, Relapse Rate And Brain Atrophy In Multiple Sclerosis Patients: Review Of Literature And Pharmacoeconomic Considerations.
Predictors of exercise participation in ambulatory and non-ambulatory older people with multiple sclerosis.
Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.
Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation.
Over the past decade, we have made great advances in the field of multiple sclerosis. Introduction.
Small molecules with anti-inflammatory properties in clinical development.
Effect of 10-day forced treadmill training on neurotrophic factors in experimental autoimmune encephalomyelitis.
Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis.
Lesser-known myelin-related disorders: Focal tumour-like demyelinating lesions.
Challenging AQP4 druggability for NMO-IgG antibody binding using molecular dynamics and molecular interaction fields.
Impact of depression, fatigue, and global measure of cortical volume on cognitive impairment in multiple sclerosis.
Pages
« first
‹ previous
…
635
636
637
638
639
640
641
642
643
…
next ›
last »